EloyR., BellevilleJ., RissoanM.C., BaguetJ.Heparinization of medical grade polyurethanes.J Biomat Applic1988; 2: 475–519.
4.
MunroM.S., QuattroneA.J., EllsworthS.R., KulkarniP., EberhartR.C.Alkyl-substituted polymers with enhanced albumin affinity.Trans Am Soc Artif Intern Organs1981; 27: 499–503.
5.
MerrillE.W.Distinctions and correspondences among surfaces contacting blood.Ann NY Acad Sci1987; 516: 196–302.
6.
HaywardJ.A., ChapmanD.Biomembrane surfaces as models for polymer design: the potential for haemo-compatibility.Biomat1984; 5: 135–42.
7.
IshiharaK., UedaT., NakabayashiN.Preparation of phospholipid polymers and their properties as polymer hydrogel membranes.Polym J1990; 22: 355–60.
8.
IshiharaK., AragakiR., UedaT., WatenabeA., NakabayashiN.Reduced thrombogenicity of polymers having phospholipid polar groups.J Biomed Mater Res1990; 24: 1069–77.
9.
BamfordC.H., MiddletonI.P., Al-LameeK.G.Polymeric inhibitors of platelet aggregation. Synergistic effect and proposals for a new mechanism.Biochem Biophys Acta1986; 886: 109–18.
10.
BamfordC.H., MiddletonI.P., Al-LameeK.G.Polymeric inhibitors of platelet aggregation. II. Copolymers of dipyridamole and related drugs with N-vinylpyrrolidone.Biochem Biophys Acta1987; 924: 38–44.
11.
BamfordC.H., MiddletonI.P., Al-LameeK.G.Routes to bioactive hydrophilic polymers.Polym J1987; 19: 475–83.
12.
BamfordC.H., MiddletonI.P., Al-LameeK.G.Studies of the esterification of dextran: routes to bioactive polymers and graft copolymers.Polymer1986; 27: 1981–5.
BamfordC.H., MiddletonI.P., Al-LameeK.G., PaprotnyJ., SatakeY.Modification of polymers for cardiovascular applications — some routes to bioactive hydrophilic polymers.Bull Mat Sci Indian Acad Sci1989; 12: 3–15.
15.
BamfordC.H., MiddletonI.P., SatakeY., Al-LameeK.G.Grafting and attachment of antiplatelet agents to poly (ether urethanes). In: CulbertsonB.M., McGrathJ.E., eds. Advances in polymer synthesis.New York: Plenum Press, 1984; 291–320.
16.
CaldwellA.G., HarrisC.J., StepneyR., WhittakerN.Heterocyclic prostaglandin analogues. Part 2. Hydantoins and other imidazole analogues.J Chem Soc Perkin Trans1980; 1: 495–505.
17.
WhittleB.J.R., MoncadaS., MullaneK., VaneJ.R.Platelet and cardiovascular activity of the hydantoin BW245C, a potent prostaglandin analogue.Prostaglandins1983; 25: 205–23.
18.
BamfordC.H.Organometallic derivatives of transition metals as initiators of free radical polymerization. In: JenkinsA.D., LedwithA., eds. Reactivity mechanism and structure in polymer chemistry.New York: John Wiley, 1974; 52–116.
19.
BamfordC.H.Application of transition metal derivatives in free radical synthesis and modification of polymers by photochemical methods. In: AllenN.S., RabekJ.F., eds. New trends in the photochemistry of polymers.London, Elsevier1985; 129–45.
20.
LindahlU., BackstromG., HookM., ThunbergL.A.Structure of the antithrombin-binding site of heparin.Proc Natl Acad Sci USA1979; 76: 3198–202.
21.
ChoayJ., PetitouM., LormeanJ.C., SinaryP., CasuB., GattiG.Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and factor Xa activity.Biochem Biophys Res Commun1983; 116: 492–9.